| Description |
1 online resource |
| Series |
Cancer etiology, diagnosis and treatments |
|
Cancer etiology, diagnosis, and treatments.
|
| Contents |
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) SYMPTOMS, TREATMENT AND PROGNOSIS ; DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) SYMPTOMS, TREATMENT AND PROGNOSIS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 Pathologic Diagnosis and Prognostic Markers of Diffuse Large B-Cell Lymphoma; Abstract; Introduction; Epidemiology and Clinical Features; Morphologic and Immunophenotypic Features; Differential Diagnosis; Genetic and Molecular Features; Prognostic Markers; Morphologic Subtypes and Other Entities; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma |
|
Primary DLBCL of the Central Nervous SystemPrimary Cutaneous DLBCL, Leg Type; EBV-Positive DLBCL of the Elderly; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Intravascular Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation; Lymphomatoid Granulomatosis; ALK-Positive Large B-Cell Lymphoma; Plasmablastic Lymphoma; Diffuse Large B-Cell Lymphoma with IG/IRF4 Translocation; Large B-Cell Lymphoma Arising in HHV8-Associated Multicentric Castleman Disease; Primary Effusion Lymphoma |
|
B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Classical Hodgkin LymphomaB-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Burkitt Lymphoma; References; Chapter 2 Diffuse Large B-Cell Lymphoma: Diagnosis, Treatment and Prognosis; Abstract; Introduction; Clinical Presentation of DLBCL; Prognosis of DLBCL; Pathologic Characteristics and Classification of DLBCL; DLBCL, Not Otherwise Specified (NOS); Primary Mediastinal Large B-Cell Lymphoma (PMBCL); T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; EBV-Positive DLBCL |
|
DLBCL in Specific Anatomic SitesDLBCL with Plasma Cell Immunophenotype; B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Burkitt Lymphoma; B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Hodgkin Lymphoma; Treatment of DLBCL; Current Standard of Care: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP); Treatment of Older Adults; Treatment of Patients with Cardiac Dysfunction; HIV-Associated Lymphomas; Primary Mediastinal Large B-Cell Lymphoma; Relapsed/Refractory DLBCL |
|
Future Directions in the Treatment of DLBCLTargeted Therapies for Surface Markers in DLBCL; Targeted Therapies for GCB-Type DLBCL; Targeted therapies for ABC-Type DLBCL; Chimeric Antigen Receptor T (CAR T)-Cell Therapy; Conclusion; References; Chapter 3 The Evolving Role of Radiation Therapy in the Management of Diffuse Large B-Cell Lymphoma; Abstract; Introduction; The Era of Chop; Prospective Trials; Retrospective Studies; R-CHOP Studies; Advanced Stage; Prospective Evaluation in the Era of R-CHOP; Radiation Techniques; Risk-Adapted Treatment Selection; Conclusion; References |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Description based on print version record and data provided by publisher |
| Subject |
Lymphomas.
|
|
Lymphoma, Large B-Cell, Diffuse
|
|
Lymphoma
|
|
HEALTH & FITNESS / Diseases / General
|
|
MEDICAL / Clinical Medicine
|
|
MEDICAL / Diseases
|
|
MEDICAL / Evidence-Based Medicine
|
|
MEDICAL / Internal Medicine
|
|
Lymphomas
|
| Form |
Electronic book
|
| Author |
Shao, Haipeng, editor
|
| LC no. |
2020677192 |
| ISBN |
9781634844178 |
|
1634844173 |
|
